Health-related quality of life (HRQOL) and kidney cancer-related symptoms in patients with metastatic renal cell carcinoma (MRCC) treated with sunitinib versus interferon (IFN)-alfa in a randomised, multinational phase III trial: Results for European and US subsample analyses Meeting Abstract


Authors: Cella, D.; Li, J. Z.; Bushmakin, A. G.; Cappelleri, J. C.; Kim, S. T.; Chen, F.; Charbonneau, C.; Motzer, R. J.
Abstract Title: Health-related quality of life (HRQOL) and kidney cancer-related symptoms in patients with metastatic renal cell carcinoma (MRCC) treated with sunitinib versus interferon (IFN)-alfa in a randomised, multinational phase III trial: Results for European and US subsample analyses
Meeting Title: ISPOR 10th Annual European Congress
Journal Title: Value in Health
Volume: 10
Issue: 6
Meeting Dates: 2007 Oct 20-23
Meeting Location: Dublin, Ireland
ISSN: 1098-3015
Publisher: Elsevier Science, Inc.  
Date Published: 2007-11-01
Start Page: A345
Language: English
ACCESSION: WOS:000251508900388
PROVIDER: wos
DOI: 10.1111/j.1524-4733.2007.00263_2.x
Notes: --- - Meeting Abstract: PCN72 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer